Dornase alfa non-comp unit
Products billed under this code include Pulmozyme.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Pulmozyme.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Pulmozyme | Genentech, Inc. | 50242-0100-40 | 75 | $4,260.45 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $56.806 | +$0.026 | 1 MG | Dornase alfa non-comp unit | v1, posted September 17, 2026 |
| 3Q26 | $56.78 | +$1.608 | 1 MG | Dornase alfa non-comp unit | v1, posted September 15, 2026 |
| 2Q26 | $55.172 | +$0.014 | 1 MG | Dornase alfa non-comp unit | v1, posted September 15, 2026 |
| 1Q26 | $55.158 | −$0.004 | 1 MG | Dornase alfa non-comp unit | v1, posted September 15, 2026 |
| 4Q25 | $55.162 | +$0.006 | 1 MG | Dornase alfa non-comp unit | v1, posted September 8, 2026 |
| 3Q25 | $55.156 | +$1.568 | 1 MG | Dornase alfa non-comp unit | v1, posted March 10, 2026 |
| 2Q25 | $53.588 | −$0.005 | 1 MG | Dornase alfa non-comp unit | v1, posted March 10, 2026 |
| 1Q25 | $53.593 | +$0.115 | 1 MG | Dornase alfa non-comp unit | v1, posted December 19, 2025 |
| 4Q24 | $53.478 | +$0.042 | 1 MG | Dornase alfa non-comp unit | v1, posted June 11, 2025 |
| 3Q24 | $53.436 | +$1.402 | 1 MG | Dornase alfa non-comp unit | v1, posted June 11, 2025 |
| 2Q24 | $52.034 | −$0.043 | 1 MG | Dornase alfa non-comp unit | v1, posted March 11, 2025 |
| 1Q24 | $52.077 | −$0.177 | 1 MG | Dornase alfa non-comp unit | v1, posted December 19, 2024 |
| 4Q23 | $52.254 | +$0.02 | 1 MG | Dornase alfa non-comp unit | v1, posted October 10, 2024 |
| 3Q23 | $52.234 | +$2.157 | 1 MG | Dornase alfa non-comp unit | v1, posted June 5, 2024 |
| 2Q23 | $50.077 | −$0.043 | 1 MG | Dornase alfa non-comp unit | v1, posted February 23, 2024 |
| 1Q23 | $50.12 | −$0.041 | 1 MG | Dornase alfa non-comp unit | v1, posted December 6, 2023 |
| 4Q22 | $50.161 | +$2.352 | 1 MG | Dornase alfa non-comp unit | v1, posted June 22, 2023 |
| 3Q22 | $47.809 | +$0.004 | 1 MG | Dornase alfa non-comp unit | v1, posted June 9, 2023 |
| 2Q22 | $47.805 | +$0.006 | 1 MG | Dornase alfa non-comp unit | v1, posted December 14, 2022 |
| 1Q22 | $47.799 | $0.00 | 1 MG | Dornase alfa non-comp unit | v1, posted June 8, 2022 |
| 4Q21 | $47.799 | +$0.008 | 1 MG | Dornase alfa non-comp unit | v1, posted June 2, 2022 |
| 3Q21 | $47.791 | −$0.003 | 1 MG | Dornase alfa non-comp unit | v1, posted June 2, 2022 |
| 2Q21 | $47.794 | +$0.008 | 1 MG | Dornase alfa non-comp unit | v1, posted March 1, 2022 |
| 1Q21 | $47.786 | – | 1 MG | Dornase alfa non-comp unit | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.